UNSPSC 51172136: Meladrazine or meladrazine tartrate

This classification denotes an antispasmotic agent with the molecular formulas C11H23N7 and C11H23N7.C4H6O6, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 2V6Z0JG2X0 and 7F3DYQ3H7H, the base compound being chemically known as 1,3,5-triazin-2(1h)-one, 4,6-bis(diethylamino)-, hydrazone (9ci) but generally known as meladrazine, which bears US NIH Compound Identifier 71679. European Medicines Agency schedules Meladrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB08717MIG and SUB03125MIG.

UNSPSC 51172136 Meladrazine or meladrazine tartrate is a Commodity code that in recent state and local procurement activity maps to drug testing services—specifically immunoassay screening, confirmatory testing by LC/MS/MS or GC/MS, and alternative specimen modalities (oral fluid, hair) used in criminal justice and community supervision contexts. The code does not reflect the purchase of the pharmaceutical compound itself, but rather the laboratory and collection services that employ such testing methodologies. State and local issuing bodies using this code include county community supervision and corrections departments responsible for offender monitoring and drug screening compliance. The scope encompasses not only the chemical testing itself but also specimen collection site staffing, Interactive Voice Response randomization systems, electronic result reporting, and SAMHSA, state DPS, or CAP lab certification requirements—a full-service operational footprint rather than a commodity supply contract.

Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 Offender Specimen Collection and Drug Testing Services on September 25, 2026, with responses due July 23, 2026 at 2:00 p.m., with an estimated contract value of $600,000 and a two-year base term commencing September 1, 2026, extendable through three optional one-year renewals. The county solicits staffing for collection sites in Plano and McKinney (weekday and five Saturday shifts annually), immunoassay screening with confirmation methodology, and ancillary testing to support approximately 25,031 annual tests across five-panel and six-panel configurations. Pricing is structured per test across three service models (screening only, confirmation, or screening with automatic confirmation), with freight, delivery, insurance, and staffing embedded; price redetermination is limited to annual September 1 reviews tied to medical CPI not exceeding 3.0 percent. Evaluation weights vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 additional points.